ArticleRSC advances2025
Effectiveness of fullerene/magnesium oxide nanocomposite in removing ciprofloxacin and tetracycline from aqueous solutions.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Novel zirconium-based supramolecular organic frameworks/fullerene@strontium-based MOFs composite for highly sensitive electrochemical sensing of ciprofloxacin.Mikrochimica acta · 2026Article
- Life Cycle Assessment of Synthesis Route and Regenerative Application of Novel GO/ZIF-60/CoNiAl-LTH Nanocomposite for Efficient Remediation of Ciprofloxacin Contaminated Water.Antibiotics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The excessive use of antibiotics, including ciprofloxacin (CIP) and tetracycline (TC), poses negative impacts on both human health and ecosystems. In this work, fullerene/magnesium oxide (F/MgO) nanocomposite was prepared and studied as adsorbent for CIP and TC removal. Adding metal oxide to F led to a change in its characteristics which was confirmed by XRD, FTIR, SEM, and TEM. A maximal removal for 50 mg L
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.